Unlike in NK cells in which NCR1 can be down-regulated in cancer patients [45;46] and its activity could be attenuated when exposed to tumor-expressed inhibitory ligands (such as MHC), T-cell expressing N1/28z could circumvent such an inhibition. Here, HLA-C is linked to neoplasm.